Abstract
A study was conducted to demonstrate a dual-modality nanoparticle system, capable of labeling and imaging CTL cells, expressing T-cell receptors (TCR) that recognize cognate MHC-peptide complexes on the surface of antigen-presenting tumor cells. The study demonstrated in-vivo T-cell selectivity and reporter functionality of the developed nanoparticle system, as both magnetic resonance imaging (MRI) and fluorescent contrast agent. It was demonstrated that the nanoparticle system was made of an iron oxide nanoparticle (NP), with a thin covalently bound polyethylene glycol (PEG) coating, which is functionalized with peptide-MHC monomers and coupled with the fluorophore Alexa Fluor 647. Peptide-MHC monomers were used to impart targeting specificity to the NP-PEG.
Original language | English (US) |
---|---|
Pages (from-to) | 712-715 |
Number of pages | 4 |
Journal | Small |
Volume | 4 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2008 |
Externally published | Yes |
Keywords
- Cell labeling
- Labeling efficacy
- Magnetic nanoparticles
- Magnetic resonance imaging
- Specific targeting
ASJC Scopus subject areas
- Biotechnology
- Biomaterials
- General Chemistry
- General Materials Science